ArticleCancer cell international2022

Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma.

Junwei Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.